Private equity firm Advent to sell generic drugmaker Zentiva to GTCR – Reuters

Written by

admin

in

  1. Private equity firm Advent to sell generic drugmaker Zentiva to GTCR  Reuters
  2. Zentiva, a leading European generics pharmaceutical company, announces sale from Advent to GTCR  Advent International
  3. Aurobindo Pharma shares rise 4.5% as report says GTCR strikes $4.8-bn deal to buy Zentiva  Moneycontrol
  4. Advent’s Zentiva sale is Europe’s biggest PE healthcare exit in 2025  PitchBook
  5. Private equity GTCR strikes $4.8 billion deal to buy Zentiva, FT reports  Yahoo Finance

Continue Reading

More posts